5 Advanced Solid Tumors Clinical Trials in Celebration, FL (2026)

Q: How do I join a clinical trial in Celebration?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Celebration research site will contact you.

Recruiting Advanced Solid Tumors Studies in Celebration

NCT06589596Recruiting

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

This is an open-label, multicenter, first-in-human dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity...

Celebration, FLPHASE1525 participantsBeOne Medicines

View Study Details

NCT05592626Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent administered intravenously in participants with ad...

Celebration, FLPHASE1365 participantsMarengo Therapeutics, Inc.

View Study Details

NCT06026410Recruiting

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

This first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyltransferase inhibitor (FTI), as a monotherapy and in combination, in adult patients with ad...

Celebration, FLPHASE1300 participantsKura Oncology, Inc.

View Study Details

NCT06253130Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

This study will evaluate the preliminary efficacy of IMP1734 in patients with recurrent advanced/metastatic breast cancer, ovarian cancer and metastatic castrate resistant prostate cancer (mCRPC) with...

Celebration, FLPHASE1156 participantsEikon Therapeutics

View Study Details

NCT06803680Recruiting

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

The goal of this clinical trial is to learn if BGB-B455 can treat advanced or metastatic solid tumors expressing claudin 6 (CLDN6), a protein that is found on some tumors. The main questions it aims ...

Celebration, FLPHASE190 participantsBeOne Medicines

View Study Details

About Advanced Solid Tumors Clinical Trials in Celebration

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 5 advanced solid tumors clinical trials recruiting participants in Celebration, FL. These studies are seeking a combined 1,436 participants. Research is being sponsored by BeOne Medicines, Marengo Therapeutics, Inc., Kura Oncology, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Celebration — FAQ

Are there advanced solid tumors clinical trials in Celebration?

Yes, there are 5 advanced solid tumors clinical trials currently recruiting in Celebration, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Celebration?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Celebration research site will contact you about next steps.

Are clinical trials in Celebration free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Celebration studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 5 active trials in Celebration are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated July 22, 2026 from ClinicalTrials.gov